Cytokine responses to Staphylococcus aureus bloodstream infection differ between patient cohorts that have different clinical courses of infection

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  McNicholas, Sinead ^a   Talento, Alida Fe ^a   O'Gorman, Joanne ^b   Hannan, Margaret M ^b   Lynch, Maureen ^b   Greene, Catherine M ^c   Humphreys, Hilary ^a   Fitzgerald Hughes, Deirdre ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Bloodstream infection; Haemodialysis; IL 6; Immune mediator; Leptin; Pro inflammatory cytokine; RANTES; Renal impairment; Staphylococcus aureus

Indexed keywords

CXCL3 CHEMOKINE; INTERLEUKIN 6; LEPTIN; RANTES; BIOLOGICAL MARKER; CYTOKINE;

ADULT; AGED; ARTICLE; BACTERIAL ENDOCARDITIS; BLOODSTREAM INFECTION; CYTOKINE RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; PROGNOSIS; PROSPECTIVE STUDY; STAPHYLOCOCCUS INFECTION; BACTEREMIA; BLOOD; COMPARATIVE STUDY; COMPLICATION; ISOLATION AND PURIFICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; STAPHYLOCOCCUS AUREUS;

AGED; BACTEREMIA; BIOMARKERS; CYTOKINES; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84965186219     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-014-0580-6     Document Type: Article

References (26)

1. Lindsay JA, Holden MT: Understanding the rise of the superbug: investigation of the evolution and genomic variation of Staphylococcus aureus. Funct Integr Genomics 2006, 6(3):186-201.
2. Fowler VG Jr, Nelson CL, McIntyre LM, Kreiswirth BN, Monk A, Archer GL, Federspiel J, Naidich S, Remortel B, Rude T, Brown P, Reller LB, Corey GR, Gill SR: Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infection. J Infect Dis 2007, 196(5):738-747.
3. Takata T, Miyazaki M, Futo M, Hara S, Shiotsuka S, Kamimura H, Yoshimura H, Matsunaga A, Nishida T, Ishikura H, Tamura K, Tsuji BT: Presence of both heterogeneous vancomycin-intermediate resistance and beta-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection. Scand J Infect Dis 2013, 45(3):203-212.
4. Verkaik NJ, Dauwalder O, Antri K, Boubekri I, de Vogel CP, Badiou C, Bes M, Vandenesch F, Tazir M, Hooijkaas H, Verbrugh HA, van Belkum A, Etienne J, Lina G, Ramdani-Bouguessa N, van Wamel WJ: Immunogenicity of toxins during Staphylococcus aureus infection. Clin Infect Dis 2010, 50(1):61-68.
5. Santos SS, Brunialti MK, Rigato O, Machado FR, Silva E, Salomao R: Generation of nitric oxide and reactive oxygen species by neutrophils and monocytes from septic patients and association with outcomes. Shock 2012, 38(1):18-23.
6. Fowler VJ, Justice A, Moore C, Benjamin DK Jr, Woods CW, Campbell S, Reller LB, Corey GR, Day NP, Peacock SJ: Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis 2005, 40(5):695-703.
7. Wang JE, Jorgensen PF, Almlof M, Thiemermann C, Foster SJ, Aasen AO, Solberg R: Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model. Infect Immun 2000, 68(7):3965-3970.
8. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ: Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002, 137(10):791-797.
9. Peres AG, Madrenas J: The broad landscape of immune interactions with Staphylococcus aureus: from commensalism to lethal infections. Burns 2013, 39(3):380-388.
10. Yao L, Bengualid V, Lowy FD, Gibbons JJ, Hatcher VB, Berman JW: Internalization of Staphylococcus aureus by endothelial cells induces cytokine gene expression. Infect Immun 1995, 63(5):1835-1839.
11. Strindhall J, Lindgren PE, Lofgren S, Kihlstrom E: Clinical isolates of Staphylococcus aureus vary in ability to stimulate cytokine expression in human endothelial cells. Scand J Immunol 2005, 61(1):57-62.
12. Berbari E, Mabry T, Tsaras G, Spangehl M, Erwin PJ, Murad MH, Steckelberg J, Osmon D: Inflammatory blood laboratory levels as markers of prosthetic joint infection: a systematic review and meta-analysis. J Bone Joint Surg 2010, 92(11):2102-2109.
13. Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimont P, Lamy M: Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992, 215(4):356-362.
14. Hack CE, De Groot ER, Felt-Bersma RJ, Nuijens JH, Strack Van Schijndel RJ, Eerenberg-Belmer AJ, Thijs LG, Aarden LA: Increased plasma levels of interleukin-6 in sepsis. Blood 1989, 74(5):1704-1710.
15. Uusitalo-Seppala R, Koskinen P, Leino A, Peuravuori H, Vahlberg T, Rintala EM: Early detection of severe sepsis in the emergency room: diagnostic value of plasma C-reactive protein, procalcitonin, and interleukin-6. Scand J Infect Dis 2011, 43(11-12):883-890.
16. Feezor RJ, Oberholzer C, Baker HV, Novick D, Rubinstein M, Moldawer LL, Pribble J, Souza S, Dinarello CA, Ertel W, Oberholzer A: Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria. Infect Immun 2003, 71(10):5803-5813.
17. Jekarl DW, Lee SY, Lee J, Park YJ, Kim Y, Park JH, Wee JH, Choi SP: Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis. Diagn Microbiol Infect Dis 2013, 75(4):342-347.
18. Venge J, Lampinen M, Hakansson L, Rak S, Venge P: Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung. J Allergy Clin Immunol 1996, 97(5):1110-1115.
19. Megyeri K, Mandi Y, Degre M, Rosztoczy I: Induction of cytokine production by different Staphylococcal strains. Cytokine 2002, 19(4):206-212.
20. Kanangat S, Postlethwaite A, Cholera S, Williams L, Schaberg D: Modulation of virulence gene expression in Staphylococcus aureus by interleukin-1beta: novel implications in bacterial pathogenesis. Microbes Infect 2007, 9(3):408-415.
21. Arnalich F, Lopez J, Codoceo R, Jimnez M, Madero R, Montiel C: Relationship of plasma leptin to plasma cytokines and human survivalin sepsis and septic shock. J Infect Dis 1999, 180(3):908-911.
22. Bornstein SR, Licinio J, Tauchnitz R, Engelmann L, Negrao AB, Gold P, Chrousos GP: Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. J Clin Endocrinol Metab 1998, 83(1):280-283.
23. Shapiro NI, Khankin EV, Van Meurs M, Shih SC, Lu S, Yano M, Castro PR, Maratos-Flier E, Parikh SM, Karumanchi SA, Yano K: Leptin exacerbates sepsis-mediated morbidity and mortality. J Immunol 2010, 185(1):517-524.
24. Hultgren OH, Tarkowski A: Leptin in septic arthritis: decreased levels during infection and amelioration of disease activity upon its administration. Arthritis Res 2001, 3(6):389-394.
25. Vaudaux PE, Monzillo V, Francois P, Lew DP, Foster TJ, Berger-Bachi B: Introduction of the mec element (methicillin resistance) into Staphylococcus aureus alters in vitro functional activities of fibrinogen and fibronectin adhesins. Antimicrob Agents Chemother 1998, 42(3):564-570.
26. Otto M: Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus. Annu Rev Microbiol 2010, 64:143-162.